Cited by 337Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Dunaif, Andrea, Wu, Xinqi, Lee, Anna, Diamanti-Kandarakis, Evanthia·2001·American Journal of Physiology-Endocrinology and Metabolism

DOI 10.1152/ajpendo.2001.281.2.e392

Open this paper in CoChat — free account

Abstract

Women with polycystic ovary syndrome (PCOS) are insulin resistant secondary to a postbinding defect in insulin signaling. Sequential euglycemic glucose clamp studies at 40 and 400 mU · m −2 · min −1 insulin doses with serial skeletal muscle biopsies were performed in PCOS and age-, weight-, and ethnicity-matched control women. Steady-state insulin levels did not differ, but insulin-mediated glucose disposal was significantly decreased in PCOS women ( P < 0.05). Insulin receptor substrate (IRS)-1-associated phosphatidylinositol 3-kinase (PI 3K) activity was significantly decreased in PCOS ( n = 12) compared with control skeletal muscle ( n = 8; P < 0.05). There was no significant difference in the abundance of IR, IRS-1, or the p85 regulatory subunit of PI 3K in PCOS ( n = 14) compared with control ( n = 12) muscle. The abundance of IRS-2 was significantly increased ( P < 0.05) in PCOS skeletal muscle, suggesting a compensatory change. We conclude that there is a physiologically relevant defect in insulin receptor signaling in PCOS that is independent of obesity and type 2 diabetes mellitus.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.2001.281.2.e392

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
Self-citation
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Self-citation
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Self-citation
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139
Phosphatidylinositol 3-Kinase Activation Is Required for Insulin Stimulation of pp70 S6 Kinase, DNA Synthesis, and Glucose Transporter Translocation
Cheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
Signaling pathways in insulin action: molecular targets of insulin resistance
Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939
Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.
Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41901-6 · Cited by 911

Show all 41 references

Research works printed but not linked: 10

Book CB, 1999, J Clin Endocrinol Metab, 84, 3110
10.1128/MCB.14.7.4902 · DOI
Ciaraldi TP, 1992, J Clin Endocrinol Metab, 75, 577
DeFronzo RA., 1997, Diabetes Rev, 5, 177
Dunaif A., 1997, Endocr Rev, 18, 774
Dunaif A, 1996, J Clin Endocrinol Metab, 81, 3299
Evans WJ, 1982, Med Sci Sports Exerc, 14, 101
Knochenhauser ES, 1998, J Clin Endocrinol Metab, 83, 3078
Legro RS, 1999, J Clin Endocrinol Metab, 84, 165
White MF., 1998, Recent Prog Horm Res, 53, 119

Sorted by citations

Polycystic ovary syndrome
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citation
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Self-citation
Polycystic Ovary Syndrome
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,920
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Impaired Glucose Tolerance, Type 2 Diabetes and Metabolic Syndrome in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
Rojas, J., Chávez-Castillo, M., Olivar, L. C., Rojas, M., Morillo, J., Mejias, J. A., Calvo, M. C. C., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/719050 · Cited by 504
PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors
Broekmans, F. J., Knauff, E. A. H., Valkenburg, O., Laven, J. S. E., Eijkemans, M. J. C., & Fauser, B. C. J. M. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01008.x · Cited by 445
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque‐Ramírez, M., & Millán, J. L. S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 426
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-022-01091-0 · Cited by 408
Ethnicity, Obesity and the Prevalence of Impaired Glucose Tolerance and Type 2 Diabetes in PCOS: A Systematic Review and Meta-Regression
Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy007 · Cited by 384
Insulin and hyperandrogenism in women with polycystic ovary syndrome
Baptiste, C. G., Battista, M., Trottier, A., & Baillargeon, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.010 · Cited by 368
Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome
Spritzer, P. M., Lecke, S. B., Satler, F., & Morsch, D. M. (2015) · Reproduction · doi:10.1530/rep-14-0435 · Cited by 330
Molecular mechanisms of insulin resistance in polycystic ovary syndrome
Diamanti-Kandarakis, E., & Papavassiliou, A. G. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.006 · Cited by 301
Self-citation
Polycystic ovary syndrome: Syndrome XX?
Sam, S., & Dunaif, A. E. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.08.002 · Cited by 302
Self-citation
Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294
Self-citation
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
Leo, V. D., Marca, A. L., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 291
miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin Resistance
Chen, Y.-H., Heneidi, S. G., Lee, J.-M., Layman, L. C., Stepp, D. W., Gamboa, G. M., Chen, B.-S., Chazenbalk, G. D., & Azziz, R. (2013) · Diabetes · doi:10.2337/db12-0963 · Cited by 291
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling
Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283
Self-citation
Exercise therapy in polycystic ovary syndrome: a systematic review
Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq045 · Cited by 267
Polycystic ovary syndrome current status and future perspective
Naz, R. K. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e695 · Cited by 273
Sheep models of polycystic ovary syndrome phenotype
Padmanabhan, V., & Veiga‐Lopez, A. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.005 · Cited by 222
Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome
Skov, V., Glintborg, D., Knudsen, S., Jensen, T. E., Kruse, T. A., Tan, Q., Brusgaard, K., Beck‐Nielsen, H., & Højlund, K. (2007) · Diabetes · doi:10.2337/db07-0275 · Cited by 204
Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women
Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184
Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility
Calcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study
Ollila, M.-M. E., Piltonen, T., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., & Morin-Papunen, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3543 · Cited by 182
Polycystic Ovarian Morphology with Regular Ovulatory Cycles: Insights into the Pathophysiology of Polycystic Ovarian Syndrome
Adams, J. M., Taylor, A. E., Crowley, W. F., & Hall, J. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031600 · Cited by 179
Increased levels of serum advanced glycation end‐products in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Piperi, C., Kalofoutis, A., & Creatsas, G. C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02170.x · Cited by 179
Self-citation
Metformin administration improves endothelial function in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Alexandraki, K., Protogerou, A. D., Piperi, C., Papamichael, C. M., Aessopos, A., Lekakis, J., & Mavrikakis, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01910 · Cited by 179
Self-citation
Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries
Diamanti‐Kandarakis, E., Piperi, C., Patsouris, E., Korkolopoulou, P. A., Panidis, D., Pawelczyk, L. A., Papavassiliou, A. G., & Dulęba, A. J. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0265-3 · Cited by 176
Self-citation
Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)
Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A. G., & Panidis, D. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03247.x · Cited by 172
Self-citation
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome
Goodarzi, M. O., & Azziz, R. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.005 · Cited by 170
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
Diamanti-Kandarakis, E., & Piperi, C. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi025 · Cited by 167
Self-citation
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Corbould, A. M., Zhao, H., Mirzoeva, S., Aird, F., & Dunaif, A. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0453 · Cited by 166
Self-citation
Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice
Park, C. J., Zhao, Z., Glidewell-Kenney, C., Lazic, M., Chambon, P., Krust, A., Weiss, J., Clegg, D. J., Dunaif, A., Jameson, J. L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41702 · Cited by 162
Self-citation
Insulin Augmentation of 17α-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase But Not Extracellular Signal-Regulated Kinase-1/2 in Human Ovarian Theca Cells
Munir, I., Yen, H.-W., Geller, D. H., Torbati, D., Bierden, R. M., Weitsman, S. R., Agarwal, S. K., & Magoffin, D. A. (2003) · Endocrinology · doi:10.1210/en.2003-0329 · Cited by 163
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
Sending the Signal: Molecular Mechanisms Regulating Glucose Uptake
Krook, A., Wallberg‐Henriksson, H., & Zierath, J. R. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000132387.25853.3b · Cited by 152
Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome
Wu, X. K., Zhou, S. Y., Liu, J. X., Pöllänen, P., Sallinen, K., Mäkinen, M., & Erkkola, R. U. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01007-0 · Cited by 147
Self-citation
Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
Corbould, A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.872 · Cited by 143
Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
Højlund, K., Glintborg, D., Andersen, N. R., Birk, J. B., Treebak, J. T., Frøsig, C., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2007) · Diabetes · doi:10.2337/db07-0706 · Cited by 146
PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update
Makker, A., Goel, M. M., Das, V., & Ak, A. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.583955 · Cited by 142
Insulin Resistance in PCOS
Diamanti‐Kandarakis, E. (2006) · Endocrine · doi:10.1385/endo:30:1:13 · Cited by 137
Self-citation
Role of obesity and adiposity in polycystic ovary syndrome
Diamanti‐Kandarakis, E. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803730 · Cited by 129
Self-citation
Skeletal Muscle Insulin Resistance in Endocrine Disease
Peppa, Μ., Koliaki, C. C., Nikolopoulos, P., & Raptis, S. (2010) · BioMed Research International · doi:10.1155/2010/527850 · Cited by 129
Polycystic Ovary Syndrome Is Associated with Tissue-Specific Differences in Insulin Resistance
Ciaraldi, T. P., Aroda, V. R., Mudaliar, S. R. D., Chang, R. J., & Henry, R. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1492 · Cited by 130
Implications and Future Perspectives of AGEs in PCOS Pathophysiology
Merhi, Z. O., Kandaraki, E., & Diamanti‐Kandarakis, E. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.01.005 · Cited by 126
Self-citation
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Bril, F., Ezeh, U., Amiri, M., Hatoum, S., Pace, L., Chen, Y.-H., Bertrand, F., Gower, B., & Azziz, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad356 · Cited by 123
Insulin resistance and polycystic ovary syndrome
Galluzzo, A., Amato, M. C., & Giordano, C. S. D. S. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.05.004 · Cited by 122
Physical activity and mental health in women with Polycystic Ovary Syndrome
Banting, L. K., Gibson-Helm, M., Polman, R., Teede, H. J., & Stepto, N. K. (2014) · BMC Women's Health · doi:10.1186/1472-6874-14-51 · Cited by 121
Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double‐blind placebo controlled clinical trial
Hajimonfarednejad, M., Nimrouzi, M., Heydari, M., Zarshenas, M. M., Raee, M. J., & Jahromi, B. N. (2017) · Phytotherapy Research · doi:10.1002/ptr.5970 · Cited by 122
Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
Lorenzo, M. D., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00479-8 · Cited by 149
Indices of low-grade inflammation in polycystic ovary syndrome
DIAMANTI‐KANDARAKIS, E., PATERAKIS, T., & KANDARAKIS, H. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.015 · Cited by 112
Self-citation
Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria
Kauffman, R. P., Baker, T. E., Baker, V. M., DiMarino, P., & Castracane, V. D. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.037 · Cited by 113
Decreased Insulin Receptor (IR) Autophosphorylation in Fibroblasts from Patients with PCOS: Effects of Serine Kinase Inhibitors and IR Activators
Li, M., YOUNGREN, J. F., Dunaif, A. E., Goldfine, I. D., Maddux, B. A., Zhang, B. B., & Evans, J. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020363 · Cited by 110
Self-citation
Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS)
Diamanti‐Kandarakis, E., Argyrakopoulou, G., Economou, F., Kandaraki, E., & Koutsilieris, M. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.014 · Cited by 107
Self-citation
Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome
Cheung, L. P., Ma, R. C. W., Lam, P. M., Lok, I. H., Haines, C. J., So, W. Y., Tong, P. C. Y., Cockram, C. S., Chow, C. C., & Goggins, W. B. (2008) · Human Reproduction · doi:10.1093/humrep/den090 · Cited by 108
DNA methylation in the pathogenesis of polycystic ovary syndrome
Vázquez-Martínez, E. R., Gómez-Viais, Y. I., García-Gómez, E., Reyes-Mayoral, C., Reyes-Muñoz, E., Camacho‐Arroyo, I., & Cerbón, M. A. (2019) · Reproduction · doi:10.1530/rep-18-0449 · Cited by 111
Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients
Koistinen, H. A., Chibalin, A., & Zierath, J. R. (2003) · Diabetologia · doi:10.1007/s00125-003-1196-3 · Cited by 108
Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)
Tan, S., Scherag, A., Janssen, O. E., Hahn, S., Lahner, H., Dietz, T., Scherag, S., Grallert, H., Vogel, C. I. G., Kimmig, R., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-12 · Cited by 103
Obesity, body composition and metabolic disturbances in polycystic ovary syndrome
Svendsen, P. F., Nilas, L., Nørgaard, K., Jensen, J. B., & Madsbad, S. (2008) · Human Reproduction · doi:10.1093/humrep/den211 · Cited by 103
Relationship of Insulin Receptor Substrate-1 and -2 Genotypes to Phenotypic Features of Polycystic Ovary Syndrome
Ehrmann, D. A., Tang, X. A., Yoshiuchi, I., Cox, N. J., & Bell, G. I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020216 · Cited by 99
Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome
Nilsson, E., Benrick, A., Kokosar, M., Krook, A., Lindgren, E., Källman, T., Martis, M. M., Højlund, K., Ling, C., & Stener-Victorin, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00935 · Cited by 93
Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish
Yan, Y., Desvignes, T., Bremiller, R., WILSON, C. A., Dillon, D. M., High, S. K., Draper, B. W., Buck, C. L., & Postlethwait, J. H. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24579 · Cited by 95
Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
Mukherjee, S., & Maitra, A. (2010) · PubMed · Cited by 92
miR-483–5p and miR-486–5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome
Shi, L., Liu, S., Zhao, W., & Shi, J. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.06.023 · Cited by 93
Mechanisms IN endocrinology: metabolic syndrome through the female life cycle
Vryonidou, A., Paschou, S. A., Muscogiuri, G., Orio, F., & Goulis, D. G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0275 · Cited by 88
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction
Józkowiak, M., Piotrowska‐Kempisty, H., Kobylarek, D., Gorska, N., Mozdziak, P. E., Kempisty, B., Rachoń, D., & Spaczyński, R. (2022) · Cells · doi:10.3390/cells12010174 · Cited by 96
Polycystic Ovary Syndrome, Obesity and Reproductive Implications
Hirschberg, A. L. (2009) · Women s Health · doi:10.2217/whe.09.39 · Cited by 85
Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome
Johansson, J., Feng, Y., Shao, R., Lönn, M., Billig, H., & Stener‐Victorin, E. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2010 · Cited by 81
The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome
Harrison, C. L., Stepto, N. K., Hutchison, S. K., & Teede, H. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04160.x · Cited by 80
Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls
Villuendas, G., Botella-Carretero, J. I., Roldán, B., Sancho, J., Escobar-Morreale, H. F., & Millán, J. L. S. (2005) · Human Reproduction · doi:10.1093/humrep/dei205 · Cited by 79
Ovarian Hypertension: Polycystic Ovary Syndrome
Bentley–Lewis, R., Seely, E. W., & Dunaif, A. E. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.009 · Cited by 83
Self-citation
Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome
Ma, X., Fan, L., Meng, Y., Hou, Z., Mao, Y., Wang, W., Ding, W., & Liu, J. (2007) · Molecular Human Reproduction · doi:10.1093/molehr/gam036 · Cited by 78
New biomarkers for diagnosis and management of polycystic ovary syndrome
Karakas, S. E. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.009 · Cited by 81
Long term complications of polycystic ovary syndrome (PCOS)
Peigné, M., & Dewailly, D. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.07.111 · Cited by 81
Cardiovascular risk in women with polycystic ovary syndrome
Giallauria, F., Orio, F., Palomba, S., Lombardi, G., Colao, A., & Vigorito, C. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32830b58d4 · Cited by 76
Molecular Mechanisms in Skeletal Muscle Underlying Insulin Resistance in Women Who Are Lean With Polycystic Ovary Syndrome.
Hansen, S., Svendsen, P., Jeppesen, J., Høeg, L. D., Andersen, N. R., Kristensen, J. M., Nilas, L., Lundsgaard, A., Wojtaszewski, J., Madsbad, S., et al. (2018) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2018-01771 · Cited by 69
Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques—A Literature Review
Reyes-Muñoz, E., Sathyapalan, T., Rossetti, P., Shah, M., Long, M., Buscema, M., Valenti, G., Rosa, V. L. L., Cianci, S., & Vitale, S. G. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0810-1 · Cited by 75
In vitro evidence that hyperglycemia stimulates tumor necrosis factor-α release in obese women with polycystic ovary syndrome
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06579 · Cited by 76
Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Alexandraki, K., Piperi, C., Aessopos, A., Paterakis, T., Katsikis, I., & Panidis, D. (2006) · Metabolism · doi:10.1016/j.metabol.2006.09.006 · Cited by 75
Self-citation
Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome
Ujvari, D., Hulchiy, M., Calaby, A., Nybacka, A., Bystrom, B., & Hirschberg, A. L. (2014) · Human Reproduction · doi:10.1093/humrep/deu114 · Cited by 72
Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study
Penna, I. A. A., Canella, P. R. B., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2005) · Human Reproduction · doi:10.1093/humrep/dei104 · Cited by 72
Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Houston, E. J., & Templeman, N. M. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0269 · Cited by 93
From Receptor to Effector: Insulin Signal Transduction in Skeletal Muscle from Type II Diabetic Patients
Zierath, J. R., & Wallberg‐Henriksson, H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04270.x · Cited by 71
Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance
Cree‐Green, M., Bergman, B. C., Coe, G. V., Newnes, L., Baumgartner, A., Bacon, S. D., Scherzinger, A. L., Pyle, L. L., & Nadeau, K. J. (2016) · Obesity · doi:10.1002/oby.21651 · Cited by 70
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69
Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome
Li, S., Zhai, J., Chu, W., Geng, X., Chen, Z., & Du, Y. (2020) · Translational research · doi:10.1016/j.trsl.2020.02.003 · Cited by 69
Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome
Ely, B. R., Clayton, Z. S., McCurdy, C. E., Pfeiffer, J. D., Needham, K. W., Comrada, L. N., & Minson, C. T. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00549.2018 · Cited by 72
Resistance exercise impacts lean muscle mass in women with polycystic ovary syndrome
KOGURE, G. S., MIRANDA-FURTADO, C. L., SILVA, R. C., MELO, A. S., FERRIANI, R. A., DE SÁ, M. F. S., & REIS, R. M. D. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000822 · Cited by 68
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
Glintborg, D., Hermann, A. P., Andersen, M., Hagen, C., Beck‐Nielsen, H., Veldhuis, J. D., & Henriksen, J. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.067 · Cited by 68
Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes—A Potential Model for PCOS-Related Insulin Resistance
Allemand, M. C., Irving, B. A., Asmann, Y. W., Klaus, K. A., Tatpati, L., Coddington, C. C., & Nair, K. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004274 · Cited by 65
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Insulin Signalling and Resistance in Patients with Chronic Heart Failure
Kemppainen, J., Tsuchida, H., Stolen, K. Q., Karlsson, H., Björnholm, M., Heinonen, O. J., Nuutila, P., Krook, A., Knuuti, J. M., & Zierath, J. R. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042648 · Cited by 65
Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery
Seow, K., Juan, C., Hsu, Y.-P., Hwang, J., Huang, L., & Ho, L. (2007) · Human Reproduction · doi:10.1093/humrep/del466 · Cited by 64
Nutritional guidelines for the management of insulin resistance
Muscogiuri, G., Barrea, L., Caprio, M., Ceriani, F., Chavez, A. O., El Ghoch, M., Frias-Toral, E., Mehta, R. J., Mendez, V., Paschou, S. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1908223 · Cited by 63
Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions
Cardoso, R. C., Puttabyatappa, M., & Padmanabhan, V. (2015) · Neuroendocrinology · doi:10.1159/000381830 · Cited by 62
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking
Luque‐Ramírez, M., Mendieta-Azcona, C., Sánchez, J. M. D. R., Maties, M., & Escobar-Morreale, H. F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0725 · Cited by 61
Biomarkers and insulin sensitivity in women with P olycystic Ovary Syndrome: Characteristics and predictive capacity
Cassar, S., Teede, H. J., Harrison, C. L., Joham, A. E., Moran, L., & Stepto, N. K. (2014) · Clinical Endocrinology · doi:10.1111/cen.12619 · Cited by 63
Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?
Pertyńska−Marczewska, M., Diamanti‐Kandarakis, E., Zhang, J., & Merhi, Z. O. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.010 · Cited by 59
Self-citation

Authors: Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E.
Affiliations: Brigham and Women's Hospital (US)
Section of Diabetes and Metabolism, Department of Medicine, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
ORCID: Dunaif, Andrea
Wu, Xinqi
Lee, Anna
Venue: American Journal of Physiology-Endocrinology and Metabolism
Publisher: American Physiological Society
Published: 2001-08-01
Volume: 281
Issue: 2
Pages: E392-E399
ISSN: 0193-1849 (ISSN-L)
1522-1555
DOI: 10.1152/ajpendo.2001.281.2.e392
OpenAlex: W1888335775
Cited by: 337
References: 41
Citations by year: 2026: 7 · 2025: 4 · 2024: 8 · 2023: 12 · 2022: 12 · 2021: 16 · 2020: 10 · 2019: 12 · 2018: 12 · 2017: 9 · 2016: 8 · 2015: 20 · 2014: 19 · 2013: 13 · 2012: 15
FWCI: 11.14
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: polycystic ovary syndrome, insulin resistance, insulin receptor signaling, IRS-1, insulin receptor substrate 2, phosphatidylinositol 3-kinase, hyperinsulinemic-euglycemic clamp
MeSH terms: Adult, Biopsy, Blood Glucose, Chromatography, Thin Layer, Female, Glucose, Humans, Insulin, Insulin Resistance, Phosphoproteins, Polycystic Ovary Syndrome, Receptor, Insulin, RNA, Messenger, Glucose Clamp Technique, Signal Transduction, Body Mass Index, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Reverse Transcriptase Polymerase Chain Reaction, Intracellular Signaling Peptides and Proteins, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks